Department of Health and Human Services · UII 009-000000833
NIH NCI Cancer Therapy Evaluation Program (CTEP)
CIO Rating
4 - Moderately Low Risk
FY2025 Funding (PY)
$16.0M
Recompete
Low
Active Contracts
1
Recompete Signal
Recompete Probability: Low
No near-term contract end with BY funding and no sustained CIO trouble.
CIO Rating Trend
3
Oct '21
4
Apr '24
4-5 Low Risk3 Medium Risk1-2 High RiskNot Rated
Funding Trend
$14.3M
FY2020
PY$20.6M
FY2021
PY$15.2M
FY2022
PY$14.8M
FY2023
PY$15.5M
FY2024
PY$16.0M
FY2025
PYInternal funding (agency's own budget)Contribution (working-capital / inter-agency)CY = current year · BY = budget year (projected) · PY = prior year
Cost Pool Breakdown
Where the FY2025 spend went, broken down by category.
External Labor
$231K
Software
$32K
Other
$4K
Internal Labor
$3K
Hardware
$2K
Outside Services
$2K
Active Contracts
| Prime | PIID | Amount | PoP Start | PoP End |
|---|---|---|---|---|
| — | 75N91022F00001 | — | — | — |
Get the AI Pursuit Report for "NIH NCI Cancer Therapy Evaluation Program (CTEP)"
Strategic interpretation, personalized fit score (NAICS + certs + past performance), incumbent analysis, and win-themes recommendations. ~6-8 page PDF, generated in 30 seconds.
$49 per report
Or included in Pro ($799/mo, 25 reports/month) and Enterprise (unlimited)